TY - JOUR T1 - A model for COVID-19 transmission in Connecticut JF - medRxiv DO - 10.1101/2020.06.12.20126391 SP - 2020.06.12.20126391 AU - Olga Morozova AU - Zehang Richard Li AU - Forrest W. Crawford Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/16/2020.06.12.20126391.abstract N2 - To support public health policymakers in Connecticut as they begin phased lifting of social distancing restrictions, we developed a county-structured compartmental SEIR-type model of SARS-CoV-2 transmission and COVID-19 disease progression. We calibrated this model to the local dynamics of deaths and hospitalizations and the exact timing of state interventions, including school closures and stay-at-home order. In this technical report, we describe the details of the model design, implementation and calibration, and show projections of epidemic development through the Summer of 2020 under different assumptions about the increase in contact rates following partial state reopening. Our model results are consistent with high effectiveness of state lockdown measures, but changes in human interaction patterns during the coming months are unknown. In addition, a lot of uncertainty remains with respect to several key epidemiological parameters and the effectiveness of increased testing and contact tracing capacity. As more information becomes available, we will update the projections presented in this report. Reports in this series are posted to https://crawford-lab.github.io/covid19_ct/.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge NIH/NICHD grant 1DP2HD091799-01.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This analysis does not use individual-level patient data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code used in this analysis are available from https://crawford-lab.github.io/covid19_ct/. https://crawford-lab.github.io/covid19_ct/ ER -